C. Kraaijeveld

发表

Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies

H. Snippe, M. Harmsen, W. A. Boere, 2005, Archives of Virology.

Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV.

R. Meloen, B. Golding, H. Golding, 1998, Vaccine.

Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines.

R. Meloen, H. Snippe, M. Harmsen, 1998, Vaccine.

A shared idiotope among antibodies against Semliki Forest virus.

N. Bos, H. Snippe, M. Harmsen, 1994, Viral immunology.

Inhibition of Semliki Forest virus multiplication in L-cells by combinations of interferon and ribavirin as measured by plaque titration and direct enzyme immunoassay.

T. Harmsen, C. Kraaijeveld, D. van Veenendaal, 1994, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

Requirements for Induction of Semliki Forest Virus Neutralizing Antibodies by a Non-Internal Image Monoclonal Antibody

H. Snippe, C. Kraaijeveld, T. Oosterlaken, 1993 .

Detection by a solid phase independent enzyme immunoassay of monoclonal anti-idiotypic antibodies against monoclonal antibodies neutralizing Semliki Forest virus and encephalomyocarditis virus.

H. Snippe, M. Harmsen, C. Kraaijeveld, 1993, Journal of virological methods.

A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.

H. Snippe, B. Benaissa-Trouw, C. Kraaijeveld, 1992, Antiviral research.

Efficient induction of Semliki Forest virus and mumps virus neutralizing anti-anti-idiotypic antibodies using Quil A as adjuvant.

H. Snippe, P. Schielen, C. Kraaijeveld, 1991, Journal of immunological methods.

A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice

H. Snippe, M. Harmsen, C. Kraaijeveld, 1991, Journal of virology.

Blocking by Anti‐Idiotypic Antibodies of Monoclonal Antibody‐Mediated Protection Against Lethal Semliki Forest Virus in Mice

H. Snippe, M. Harmsen, C. Kraaijeveld, 1990, Scandinavian journal of immunology.

Identification of a DTH-inducing T-cell epitope on the E2 membrane protein of Semliki Forest virus.

H. Snippe, B. Benaissa-Trouw, J. Oosting, 1989, Cellular immunology.

Comparison of Neutralizing and Hemagglutination-Inhibiting Antibody Responses to Influenza A Virus Vaccination of Human Immunodeficiency Virus-Infected Individuals

M. Harmsen, J. D. de Jong, J. C. Jong, 1998, Clinical Diagnostic Laboratory Immunology.

Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies

F. Vlaspolder, H. Snippe, M. Harmsen, 2005, Archives of Virology.

Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages

B. Benaissa-Trouw, J. Van Strijp, C. Kraaijeveld, 1997, European journal of immunology.

Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E

M. R. Macnaughton, S. Reed, C. Kraaijeveld, 1980, Journal of clinical microbiology.

Blocking by anti-idiotypic antibodies of monoclonal antibody mediated protection in mice against encephalomyocarditis virus induced diabetes and lethal disease

F. Vlaspolder, H. Snippe, M. Harmsen, 2005, Archives of Virology.

Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A.

A. Algra, J. Verhoef, J. Cornelissen, 1993, The Journal of infectious diseases.

Interactions of surfactant protein A with influenza A viruses: binding and neutralization.

M. Harmsen, J. Verhoef, J. V. van Strijp, 1995, The Journal of infectious diseases.

Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus

H. Snippe, T. Harmsen, T. Erich, 1985, Journal of virology.

Enzyme-linked immunosorbent assay for coronaviruses HCV 229E and MHV 3.

M. R. Macnaughton, M. Madge, C. Kraaijeveld, 1980, The Journal of general virology.

Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis.

H. Snippe, M. Harmsen, B. Benaissa-Trouw, 1983, The Journal of general virology.

Neutralization enzyme immunoassay for influenza virus

J. D. de Jong, M. Harmsen, C. Kraaijeveld, 1994, Journal of clinical microbiology.

Determination of inhibitory concentrations of antiviral agents in cell culture by use of an enzyme immunoassay with virus-specific, peroxidase-labeled monoclonal antibodies

F. V. van Tiel, H. Snippe, T. Harmsen, 1985, Antimicrobial Agents and Chemotherapy.

Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants.

A. Verheul, H. Snippe, M. Harmsen, 1997, Vaccine.

Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus

H. Snippe, M. Harmsen, B. Benaissa-Trouw, 1993, Journal of virology.

Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities

J. Vinjé, H. Snippe, T. Harmsen, 1984, Journal of virology.

Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus

H. Snippe, M. Harmsen, B. Benaissa-Trouw, 1986, Archives of Virology.

Discrimination of the determinant specificity of two competitive Semliki Forest virus neutralizing monoclonal antibodies by anti-idiotypic antibodies

H. Snippe, M. Harmsen, B. Benaissa-Trouw, 2005, Archives of Virology.

Homology of ab1 and ab3 monoclonal antibodies that neutralize Semliki Forest virus.

N. Bos, A. Verheul, H. Snippe, 2001, Viral immunology.

Inhibition by lipid A-specific monoclonal antibodies of priming of human polymorphonuclear leucocytes by endotoxin.

J. Verhoef, J. Cornelissen, C. van Kessel, 1991, Journal of medical microbiology.

Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine.

R. Meloen, W. Puijk, H. Snippe, 1991, The Journal of general virology.

Efficient Anti-Idiotypic Immunization with Homologous, Virus Neutralizing Monoclonal Antibodies Conjugated with KLH and Combined with Quil A

H. Snippe, T. Harmsen, C. Kraaijeveld, 1991 .

Competition binding assay in cell culture for identification of epitopes on enveloped and naked viruses.

F. Vlaspolder, H. Snippe, T. Harmsen, 1989, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

A neutralization-inhibition enzyme immunoassay for anti-idiotypic antibodies that block monoclonal antibodies neutralizing Semliki Forest virus.

H. Snippe, P. Schielen, M. Harmsen, 1988, Journal of immunological methods.

Application of immunoassay of encephalomyocarditis virus in cell culture with enzyme-labeled virus-specific monoclonal antibodies for rapid detection of virus, neutralizing antibodies, and interferon

F. Vlaspolder, H. Snippe, T. Harmsen, 1988, Journal of clinical microbiology.

Enzyme immunoassay of mumps virus in cell culture with peroxidase-labelled virus specific monoclonal antibodies and its application for determination of antibodies.

F. V. van Tiel, H. Snippe, T. Harmsen, 1988, Journal of virological methods.

Discrimination of determinant specificity of two encephalomyocarditis virus neutralizing monoclonal antibodies by competition, mixed neutralization and anti-idiotypic antibodies.

F. Vlaspolder, H. Snippe, B. Benaissa-Trouw, 1988, Journal of virological methods.

Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies

F. V. van Tiel, H. Snippe, T. Harmsen, 1986, Journal of clinical microbiology.

Inhibition of Semliki Forest virus multiplication by ribavirin: a potential method for the monitoring of antiviral agents in serum.

F. V. van Tiel, H. Snippe, M. Harmsen, 1986, Journal of virological methods.

Enzyme immunoassay of interferon with peroxidase-labelled virus-specific monoclonal antibodies.

F. V. van Tiel, H. Snippe, T. Harmsen, 1985, The Journal of general virology.

Rapid detection of Semliki Forest virus replication in cell culture with peroxidase-labeled monoclonal antibodies: determination of inhibitory concentrations of monoclonal antibodies and ribavirin.

F. V. van Tiel, H. Snippe, T. Harmsen, 1985, Antiviral research.

Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.

H. Snippe, W. A. Boere, C. Kraaijeveld, 1985, Antiviral research.

Delayed-type hypersensitivity against Semliki Forest virus in mice

M. Harmsen, C. Kraaijeveld, B. Khader Boutahar-Trouw, 1979, Infection and immunity.

Cellular immunity against Semliki Forest virus in mice

M. Harmsen, C. Kraaijeveld, B. Khader Boutahar-Trouw, 1979, Infection and immunity.

Detection of a shared idiotope on two encephalomyocarditis virus neutralizing monoclonal antibodies by neutralization inhibition enzyme immunoassay.

F. Vlaspolder, H. Snippe, M. Harmsen, 1993, Journal of virological methods.

Discrimination by rabbit anti-idiotypic antibodies of two murine IgM monoclonal antibodies directed against lipid A.

J. Verhoef, J. Cornelissen, R. Torensma, 1990, Journal of immunological methods.

Effect of the adjuvant dimethyl dioctadecyl ammonium bromide on the humoral and cellular immune responses to encephalomyocarditis virus.

H. Snippe, T. Harmsen, B. Benaissa-Trouw, 1983, Antiviral research.

Adjuvant Directed Immune Specificity at the Epitope Level: Implications for Vaccine Development a Model Study Using Semliki Forest Virus Infection of Mice

H. Snippe, C. Kraaijeveld, I. Fernández, 1997 .

Bordetella bronchiseptica respiratory infection in a child after bone marrow transplantation.

N. Wulffraat, A. Fleer, T. Wolfs, 1999, The Pediatric infectious disease journal.

Optimization of Carriers and Adjuvants a Model Study Using Semliki Forest Virus Infection of Mice

H. Snippe, C. Kraaijeveld, I. Fernández, 1993 .

The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.

H. Snippe, T. Harmsen, T. Erich, 1986, Immunology.

Septicemia due to coagulase-negative staphylococci in a neonatal intensive care unit: clinical and bacteriological features and contaminated parenteral fluids as a source of sepsis.

M. Visser, J. Verhoef, A. Fleer, 1983, Pediatric infectious disease.

Delayed-type hypersensitivity in mice after infection with avirulent Semliki Forest virus

H. Snippe, B. Benaissa-Trouw, C. Kraaijeveld, 2005, Archives of Virology.

Epidemiology of mumps in the Netherlands

J. Wagenvoort, M. Harmsen, C. Kraaijeveld, 1980, Journal of Hygiene.

Membrane fusion activity of Semliki Forest virus in a liposomal model system: specific inhibition by Zn2+ ions.

J. Wilschut, J. Corver, H. Snippe, 1997, Virology.

Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps

G. Berbers, T. Harmsen, C. Kraaijeveld, 1992, Journal of clinical microbiology.

Dimethyl dioctadecyl ammoniumbromide as an adjuvant for delayed type hypersensitivity and cellular immunity against Semliki Forest virus in mice

H. Snippe, M. Harmsen, C. Kraaijeveld, 2005, Archives of Virology.

Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B and T cell epitopes.

H. Snippe, B. Benaissa-Trouw, C. Kraaijeveld, 1992, The Journal of general virology.